47 related articles for article (PubMed ID: 30839018)
1. Unlocking a caged lysosomal protein from a polymeric nanogel with a pH trigger.
Molla MR; Marcinko T; Prasad P; Deming D; Garman SC; Thayumanavan S
Biomacromolecules; 2014 Nov; 15(11):4046-53. PubMed ID: 25291086
[TBL] [Abstract][Full Text] [Related]
2. Antitumoral efficacy by systemic delivery of heparin conjugated polyethylenimine-plasmid interleukin-15 complexes in murine models of lung metastasis.
Zhou X; Li X; Gou M; Qiu J; Li J; Yu C; Zhang Y; Zhang N; Teng X; Chen Z; Luo C; Wang Z; Liu X; Shen G; Yang L; Qian Z; Wei Y; Li J
Cancer Sci; 2011 Jul; 102(7):1403-9. PubMed ID: 21564417
[TBL] [Abstract][Full Text] [Related]
3. A Gas Therapy Strategy for Intestinal Flora Regulation and Colitis Treatment by Nanogel-Based Multistage NO Delivery Microcapsules.
Fu YJ; Zhao X; Wang LY; Li K; Jiang N; Zhang ST; Wang RK; Zhao YF; Yang W
Adv Mater; 2024 May; 36(19):e2309972. PubMed ID: 38324725
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle-mediated tumor cell expression of mIL-12 via systemic gene delivery treats syngeneic models of murine lung cancers.
Ahn HH; Carrington C; Hu Y; Liu HW; Ng C; Nam H; Park A; Stace C; West W; Mao HQ; Pomper MG; Ullman CG; Minn I
Sci Rep; 2021 May; 11(1):9733. PubMed ID: 33958660
[TBL] [Abstract][Full Text] [Related]
5. Acoustofluidic sonoporation for gene delivery to human hematopoietic stem and progenitor cells.
Belling JN; Heidenreich LK; Tian Z; Mendoza AM; Chiou TT; Gong Y; Chen NY; Young TD; Wattanatorn N; Park JH; Scarabelli L; Chiang N; Takahashi J; Young SG; Stieg AZ; De Oliveira S; Huang TJ; Weiss PS; Jonas SJ
Proc Natl Acad Sci U S A; 2020 May; 117(20):10976-10982. PubMed ID: 32358194
[TBL] [Abstract][Full Text] [Related]
6. Enhanced therapeutic efficacy of a novel colon-specific nanosystem loading emodin on DSS-induced experimental colitis.
Wang D; Sun M; Zhang Y; Chen Z; Zang S; Li G; Li G; Clark AR; Huang J; Si L
Phytomedicine; 2020 Nov; 78():153293. PubMed ID: 32777486
[TBL] [Abstract][Full Text] [Related]
7. Multi-bioresponsive silk fibroin-based nanoparticles with on-demand cytoplasmic drug release capacity for CD44-targeted alleviation of ulcerative colitis.
Gou S; Huang Y; Wan Y; Ma Y; Zhou X; Tong X; Huang J; Kang Y; Pan G; Dai F; Xiao B
Biomaterials; 2019 Aug; 212():39-54. PubMed ID: 31103945
[TBL] [Abstract][Full Text] [Related]
8. Rab7-dependent regulation of goblet cell protein CLCA1 modulates gastrointestinal homeostasis.
Gaur P; Rajendran Y; Srivastava B; Markandey M; Fishbain-Yoskovitz V; Mohapatra G; Suhail A; Chaudhary S; Tyagi S; Yadav SC; Pandey AK; Merbl Y; Bajaj A; Ahuja V; Srikanth C
Elife; 2024 Apr; 12():. PubMed ID: 38593125
[TBL] [Abstract][Full Text] [Related]
9. Exogenous application of nanocarrier-mediated double-stranded RNA manipulates physiological traits and defence response against bacterial diseases.
Pal G; Ingole KD; Yavvari PS; Verma P; Kumari A; Chauhan C; Chaudhary D; Srivastava A; Bajaj A; Vemanna RS
Mol Plant Pathol; 2024 Jan; 25(1):e13417. PubMed ID: 38279851
[TBL] [Abstract][Full Text] [Related]
10. Self-Assembled Polymers for Gastrointestinal Tract Targeted Delivery through the Oral Route: An Update.
Yang X; Yang Y; Yu H; Zhou Y
Polymers (Basel); 2023 Aug; 15(17):. PubMed ID: 37688164
[TBL] [Abstract][Full Text] [Related]
11. Oral delivery of RNAi for cancer therapy.
Afrin H; Geetha Bai R; Kumar R; Ahmad SS; Agarwal SK; Nurunnabi M
Cancer Metastasis Rev; 2023 Sep; 42(3):699-724. PubMed ID: 36971908
[TBL] [Abstract][Full Text] [Related]
12. Ceramide Kinase (CERK) Emerges as a Common Therapeutic Target for Triple Positive and Triple Negative Breast Cancer Cells.
Rajput K; Ansari MN; Jha SK; Pani T; Medatwal N; Chattopadhyay S; Bajaj A; Dasgupta U
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139656
[TBL] [Abstract][Full Text] [Related]
13. Fatty acids produced by the gut microbiota dampen host inflammatory responses by modulating intestinal SUMOylation.
Ezzine C; Loison L; Montbrion N; Bôle-Feysot C; Déchelotte P; Coëffier M; Ribet D
Gut Microbes; 2022; 14(1):2108280. PubMed ID: 35978476
[TBL] [Abstract][Full Text] [Related]
14. Emerging role of protein modification in inflammatory bowel disease.
Wang G; Yuan J; Luo J; Ocansey DKW; Zhang X; Qian H; Xu W; Mao F
J Zhejiang Univ Sci B; 2022 Mar; 23(3):173-188. PubMed ID: 35261214
[TBL] [Abstract][Full Text] [Related]
15. Development of a Polysaccharide-Based Hydrogel Drug Delivery System (DDS): An Update.
Pushpamalar J; Meganathan P; Tan HL; Dahlan NA; Ooi LT; Neerooa BNHM; Essa RZ; Shameli K; Teow SY
Gels; 2021 Sep; 7(4):. PubMed ID: 34698125
[TBL] [Abstract][Full Text] [Related]
16. SUMOylation Connects Cell Stress Responses and Inflammatory Control: Lessons From the Gut as a Model Organ.
Karhausen J; Ulloa L; Yang W
Front Immunol; 2021; 12():646633. PubMed ID: 33679811
[TBL] [Abstract][Full Text] [Related]
17. Natural Product-Based Nanomedicine in Treatment of Inflammatory Bowel Disease.
Khare T; Palakurthi SS; Shah BM; Palakurthi S; Khare S
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486445
[No Abstract] [Full Text] [Related]
18. A nanogel based oral gene delivery system targeting SUMOylation machinery to combat gut inflammation.
Yavvari PS; Verma P; Mustfa SA; Pal S; Kumar S; Awasthi AK; Ahuja V; Srikanth CV; Srivastava A; Bajaj A
Nanoscale; 2019 Mar; 11(11):4970-4986. PubMed ID: 30839018
[TBL] [Abstract][Full Text] [Related]
19. Intracellular microenvironment-responsive label-free autofluorescent nanogels for traceable gene delivery.
Shi B; Zhang H; Qiao SZ; Bi J; Dai S
Adv Healthc Mater; 2014 Nov; 3(11):1839-48. PubMed ID: 24965262
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
